Trevi Therapeutics, Inc. Income Statement

Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.17M-0.46M-1.20M
Gross Profit -0.17M-0.46M-1.20M
Operating items
Research & Development 14.07M19.34M22.33M22.98M
Selling, General & Administrative 4.34M7.31M10.16M9.49M
Operating Expenses 18.41M26.64M32.49M32.48M
Operating Income -18.41M-26.64M-32.49M-32.48M
EBIT -18.41M-26.64M-32.49M-32.48M
Non-operating items
Interest & Investment Income 0.16M0.79M0.18M0.01M
Other Non Operating Income -0.01M0.08M
Non Operating Income -2.26M0.58M-0.29M-1.49M
Net income details
EBT -20.67M-26.07M-32.78M-33.96M
Tax Provisions -0.12M-0.02M-0.02M-0.02M
Profit After Tax -20.55M-26.05M-32.80M-33.94M
Income from Continuing Operations -20.55M-26.05M-32.76M-33.94M
Consolidated Net Income -20.55M-26.05M-32.76M-33.94M
Income towards Parent Company -20.55M-26.05M-32.76M-33.94M
Preferred Dividend Payments 5.40M2.24M
Net Income towards Common Stockholders -25.58M-26.75M-32.76M-33.94M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 17.77M17.83M18.38M25.85M59.92M63.86M76.87M
EBITDA -18.41M-26.64M-32.49M-32.48M
Tax Rate 0.60%0.07%0.05%0.06%